Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_3
1
17%
Ph phase_2
1
17%
Ph phase_1
4
67%

Phase Distribution

4

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
4(66.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (66.7%)
Phase 21 (16.7%)
Phase 31 (16.7%)

Trials by Status

completed583%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia

NCT05063994
completedphase_1

Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia

NCT02096510
terminatedphase_2

Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes

NCT01840189
completedphase_1

Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia

NCT00519818
completedphase_1

A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects

NCT03343327
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05063994Phase 3

Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia

Completed
NCT02096510Phase 1

Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia

Completed
NCT01840189Phase 2

Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes

Terminated
NCT00519818Phase 1

Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia

Completed
NCT03343327Phase 1

A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects

Completed
NCT03311932Phase 1

A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6